Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in NVCT — Nuvectis Pharma, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in NVCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,995,889
+$3,182,029 QoQ
Shares Held
217,286
+106.4% QoQ
Ownership
0.667%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 82 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVCT Over Time

Shares Held

Position Value (USD)

Derivatives in NVCT

reported options exposure · as of Jun 30, 2026
CallValue
$1,250,520
CallShares
68,000
PutValue
$461,589
PutShares
25,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. NVCT ranks #58 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVCT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $461,589 25,100
2026-06-30 $1,250,520 68,000
2026-06-30 $3,995,889 217,286
2026-03-31 $813,860 105,286
2025-12-31 $1,012,862 134,154
2025-12-31 $457,530 60,600
2025-09-30 $62,608 10,400
2025-09-30 $547,091 90,879
2025-06-30 $338,196 45,274
2025-06-30 $162,846 21,800
2025-06-30 $374,247 50,100
2025-03-31 $712,233 72,900
2025-03-31 $746,428 76,400
2024-12-31 $246,733 45,607
2024-09-30 $166,452 26,463
2023-12-31 $214,087 25,670